AB Multi-Manager Alternative Fund
Consolidated Portfolio of Investments
June 30, 2026 (unaudited)
| Underlying Portfolios | Acquisition Date |
Shares | Cost | Fair Value ($) |
% Net Assets |
Liquidity* | ||||||||||||||||||
| Multi-Strategy |
||||||||||||||||||||||||
| Aleutian Fund, Ltd. |
04/01/2025 | 42,700 | 42,700,000 | $ | 57,715,230 | 4.9 | % | Monthly | ||||||||||||||||
| Atlas Enhanced Fund, Ltd. |
02/01/2023 | 39,349 | 42,436,839 | 57,797,211 | 4.9 | Quarterly | ||||||||||||||||||
| Elliott International Limited |
04/01/2016 | 41,391 | 58,435,619 | 105,903,915 | 9.0 | Quarterly | ||||||||||||||||||
| Millennium International, Ltd. |
01/03/2022 | 29,219 | 52,037,081 | 77,737,788 | 6.6 | Quarterly | ||||||||||||||||||
| Point72 Capital International, Ltd. |
01/03/2022 | 452,584 | 66,663,745 | 121,201,081 | 10.3 | Quarterly | ||||||||||||||||||
| Whitebox Multi-Strategy Fund, Ltd. |
01/01/2025 | 20,000 | 20,000,000 | 22,861,703 | 2.0 | Quarterly | ||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Total |
443,216,928 | 37.7 | ||||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Long/Short Equity |
||||||||||||||||||||||||
| Anomaly Capital International, Ltd. |
01/01/2024 | 34,577 | 35,670,096 | 41,787,071 | 3.6 | Quarterly | ||||||||||||||||||
| Janchor Partners Pan-Asian Fund |
02/01/2016 | 13,564 | 988,836 | 748,735 | 0.1 | Triennially At Fund’s | ||||||||||||||||||
| Nokota LC, LLC(a) |
04/01/2019 | 1,118 | 970,958 | 135,805 | 0.0 | Discretion At Fund’s | ||||||||||||||||||
| PFM Healthcare Offshore Fund, Ltd. |
01/01/2018 | 322 | 221,586 | 3,505 | 0.0 | Discretion | ||||||||||||||||||
| SurgoCap Offshore Fund LP |
11/01/2024 | 35,886 | 37,000,000 | 50,898,971 | 4.3 | Quarterly | ||||||||||||||||||
| TCIM Offshore Fund, Ltd. |
07/03/2023 | 32,638 | 32,692,150 | 45,070,467 | 3.8 | Monthly | ||||||||||||||||||
| The Children’s Investment Fund |
03/01/2017 | 62,376 | 6,237,647 | 23,772,920 | 2.0 | Biennial | ||||||||||||||||||
| Think Investments Offshore Ltd. |
01/01/2014 | 8,882 | 7,075,485 | 49,056,406 | 4.2 | Semi-Annual | ||||||||||||||||||
| Viking Global Equities III, Ltd. |
12/01/2023 | 33,799 | 35,267,417 | 41,688,057 | 3.5 | Annual | ||||||||||||||||||
| Wolf Hill Offshore Fund, Ltd. |
01/01/2024 | 16,578 | 16,958,442 | 18,580,886 | 1.6 | Quarterly | ||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Total |
271,742,823 | 23.1 | ||||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Credit/Distressed |
||||||||||||||||||||||||
| Chepstow Credit Opportunities Fund |
08/01/2025 | 30,644 | 31,000,000 | 32,561,735 | 2.8 | Quarterly | ||||||||||||||||||
| Claren Road Credit Fund, Ltd. |
05/01/2025 | 5,000 | 5,000,000 | 4,998,530 | 0.4 | Quarterly | ||||||||||||||||||
| Cross Ocean GSS Offshore Feeder LP |
08/01/2023 | 44,054 | 45,901,985 | 60,191,243 | 5.1 | Quarterly | ||||||||||||||||||
| FourSixThree Overseas Fund, Ltd. |
12/01/2025 | 41,434 | 44,000,000 | 45,485,171 | 3.9 | Quarterly At Fund’s | ||||||||||||||||||
| King Street Capital, Ltd. |
10/01/2012 | 11,087 | 902,944 | 1,270,913 | 0.1 | Discretion | ||||||||||||||||||
| Primas Global Credit Fund |
08/01/2024 | 46,085 | 45,878,144 | 44,772,306 | 3.8 | Monthly | ||||||||||||||||||
| Theorem Prime+ Yield Fund Offshore LP |
06/01/2022 | 2,290 | 2,289,702 | 2,110,151 | 0.2 | Quarterly | ||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Total |
191,390,049 | 16.3 | ||||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Global Macro |
||||||||||||||||||||||||
| Alphadyne Global Rates Fund II, Ltd. |
07/01/2024 | 23,690 | 33,400,000 | 36,285,829 | 3.1 | Monthly | ||||||||||||||||||
| Caxton Macro, Ltd. |
06/02/2025 | 8,782 | 29,000,000 | 26,844,119 | 2.3 | Quarterly | ||||||||||||||||||
| Kirkoswald Global Macro Fund, Ltd. |
05/01/2026 | 450,000 | 45,000,000 | 46,037,437 | 3.9 | Quarterly | ||||||||||||||||||
| Rokos Global Macro Fund, Ltd. |
03/03/2025 | 81,155 | 20,209,392 | 25,486,431 | 2.2 | Monthly | ||||||||||||||||||
| The Tudor BVI Global Fund, Ltd. |
01/01/2019 | 202 | 31,709,539 | 51,708,842 | 4.4 | Quarterly | ||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Total |
186,362,658 | 15.9 | ||||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Event Driven |
||||||||||||||||||||||||
| Antara Capital Offshore Fund, Ltd. |
09/01/2021 | 17,680 | 24,536,115 | 4,991,954 | 0.4 | Quarterly | ||||||||||||||||||
| Astaris Special Situations Feeder Fund, Ltd. |
07/01/2024 | 203,937 | 41,093,345 | 48,013,091 | 4.1 | Quarterly | ||||||||||||||||||
| Lion Point International, Ltd. |
04/01/2015 | 2,024 | 1,538,891 | 9,857,873 | 0.9 | Semi-Annual At Fund’s | ||||||||||||||||||
| Luxor Capital Partners Offshore Liquidating SPV, Ltd. |
10/01/2012 | 2,317 | 2,326,227 | 2,636,145 | 0.2 | Discretion | ||||||||||||||||||
| Trium Khartes Fund, Ltd. |
07/01/2024 | 305,227 | 32,000,000 | 36,858,884 | 3.1 | Monthly | ||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Total |
102,357,947 | 8.7 | ||||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Total Underlying Portfolios |
1,195,070,405 | 101.7 | ||||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Participation Notes |
||||||||||||||||||||||||
| Event Driven |
||||||||||||||||||||||||
| Antara Capital Offshore Fund, Ltd.(a) |
03/31/2024 | 2,286,926 | 1,543,360 | 0.2 | ||||||||||||||||||||
| Antara Capital Offshore Fund, Ltd.(a) |
06/30/2024 | 2,027,294 | 1,526,441 | 0.1 | ||||||||||||||||||||
| Antara Capital Offshore Fund, Ltd.(a) |
09/30/2024 | 2,209,468 | 1,514,790 | 0.1 | ||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Total Participation Notes |
4,584,591 | 0.4 | ||||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
1
| Company | Shares | Fair Value ($) |
% Net Assets |
|||||||||||||||||||||
| Common Stocks |
|
|||||||||||||||||||||||
| Health Care |
|
|||||||||||||||||||||||
| Biotechnology |
|
|||||||||||||||||||||||
| Contra Chinook Therapeutics (CVR)(a) (b) |
31,520 | $ | 22,064 | 0.0 | % | |||||||||||||||||||
| Euronav NV(a) (b) |
37,922 | 379 | 0.0 | |||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Total Common Stocks |
$ | 22,443 | 0.0 | % | ||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Total Investments |
1,199,677,439 | 102.1 | ||||||||||||||||||||||
| Other assets less liabilities |
(24,233,007 | ) | (2.1 | ) | ||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
| Net Assets |
$ | 1,175,444,432 | 100.0 | % | ||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||
TOTAL RETURN SWAPS
| Counterparty & Referenced Obligation |
Rate Paid/ Received |
Payment Frequency |
Current Notional (000) |
Maturity Date |
Unrealized Appreciation (Depreciation) |
|||||||||||||||||||
| Receive Total Return on Reference Obligation |
| |||||||||||||||||||||||
| Goldman Sachs International |
| |||||||||||||||||||||||
| Resolute Forest Products |
SOFR plus 0.35% | Maturity | USD | 32 | 07/15/2027 | $ | 45,155 | |||||||||||||||||
| Merrill Lynch International |
| |||||||||||||||||||||||
| MLABHPLO(1) |
SOFR plus 0.88% | Maturity | USD | 157 | 07/31/2026 | (927 | ) | |||||||||||||||||
| Morgan Stanley Capital Services LLC |
| |||||||||||||||||||||||
| ABIOMED, Inc. |
EFFR plus 0.38% | Maturity | USD | 8 | 10/20/2026 | 21,171 | ||||||||||||||||||
|
|
|
|||||||||||||||||||||||
| $ | 65,399 | |||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||
| (a) | Security in which significant unobservable inputs (Level 3) were used in determining fair value. |
| (b) | Non-income producing security. |
| (c) | As of June 30, 2026 the cost basis of investment securities owned was substantially identical for both book and tax purposes. Gross unrealized appreciation of investments was $328,297,224 and gross unrealized depreciation of investments was $(26,220,258), resulting in net unrealized appreciation of $302,076,966. |
| * | The investment strategies and liquidity of the Underlying Portfolios in which the Fund invests are as follows: |
Multi-Strategy - Underlying Portfolios invest across multiple strategies, including long/short equity, event driven, global macro, credit/distressed and emerging markets, in which the investment process is predicated on movements in underlying economic variables and the impact these variables have on equity, fixed income, currency, commodity and other financial instrument markets. Underlying Portfolios within this strategy are generally subject to 45 – 90 day redemption notice periods. Certain Underlying Portfolios may have lock up periods of two years.
Global Macro - Underlying Portfolios aim to identify and exploit imbalances in global economics and asset classes, typically utilizing macroeconomic and technical market factors rather than “bottom-up” individual security analysis. The Underlying Portfolios within this strategy are subject to 30 – 90 day redemption notice periods. Certain Underlying Portfolios have lock up periods of up to one year.
Long/Short Equity - Underlying Portfolios seek to buy securities with the expectation that they will increase in value (“going long”) and sell securities short in the expectation that they will decrease in value (“going short”). Underlying Portfolios within this strategy are generally subject to 30 – 120 day redemption notice periods. The majority of the Underlying Portfolios are no longer subject to initial lockups. Certain Underlying Portfolios have lock up periods of up to three years.
Credit/Distressed - Underlying Portfolios invest in a variety of fixed income and other securities, including bonds (corporate and government), bank debt, asset-backed financial instruments, mortgage-backed securities and mezzanine and distressed securities, as well as securities of distressed companies and high yield securities. Underlying Portfolios within this strategy are generally subject to 30 – 90 day redemption notice periods. The majority of the Underlying Portfolios are no longer subject to initial lockups. Certain Underlying Portfolios have lock up periods of up to one year.
2
Event Driven - Underlying Portfolios seek to take advantage of information inefficiencies resulting from a particular corporate event, such as a takeover, liquidation, bankruptcy, tender offer, buyback, spin off, exchange offer, merger or other type of corporate reorganization. Underlying Portfolios within this strategy are generally subject to 60 – 90 day redemption notice periods. The majority of the Underlying Portfolios are no longer subject to initial lockups. Certain Underlying Portfolios have lock up periods of up to 18 months.
The Fund may also make direct investments in securities (other than securities of Underlying Portfolios), options, futures, options on futures, swap contracts, or other derivative or financial instruments.
Glossary:
CVR – Contingent Value Rights
EFFR – Effective Federal Funds Rate
SOFR – Secured Overnight Financing Rate
(1) The following table represents the equity basket holdings underlying the total return swap with MLABHPLO as of June 30, 2026.
| Security Description | Shares | Current Notional | Percent of Basket’s Value | ||||||||||||
| General Electric Co. | 17,697 | USD | 6,614,015 | 14.8 | % | ||||||||||
| Safran SA | 14,842 | 5,854,359 | 13.1 | % | |||||||||||
| Visa, Inc. | 13,371 | 4,587,461 | 10.3 | % | |||||||||||
| Airbus SE | 19,685 | 4,378,198 | 9.8 | % | |||||||||||
| Vinci SA | 22,084 | 3,226,725 | 7.2 | % | |||||||||||
| Vinci SA | 22,084 | 3,226,725 | 7.2 | % | |||||||||||
| Moody’s Corp. | 6,912 | 3,130,566 | 7.0 | % | |||||||||||
| S&P Global, Inc. | 7,286 | 2,806,749 | 6.3 | % | |||||||||||
| Ferrovial NV | 37,577 | 2,576,862 | 5.8 | % | |||||||||||
| Alphabet, Inc. | 5,674 | 2,004,857 | 4.5 | % | |||||||||||
| Canadian Pacific Kansas City | 20,932 | 1,813,783 | 4.1 | % | |||||||||||
| Deutsche Boerse AG | 5,344 | 1,458,935 | 3.3 | % | |||||||||||
| Aena SME SA | 35,755 | 1,089,838 | 2.4 | % | |||||||||||
| Cellnex Telecom SA | 28,221 | 843,722 | 1.9 | % | |||||||||||
| Canadian National Railway Co. | 4,463 | 532,463 | 1.2 | % | |||||||||||
| SAP SE | 2,362 | 361,804 | 0.8 | % | |||||||||||
| Mobility Global, Inc. | 5,482 | 120,876 | 0.3 | % | |||||||||||
3
AB Multi-Manager Alternative Fund
June 30, 2026 (unaudited)
U.S. GAAP establishes a framework for measuring fair value, and a three-level hierarchy for fair value measurements based upon the transparency of inputs to the valuation of an asset or liability (including those valued based on their market values). Inputs may be observable or unobservable and refer broadly to the assumptions that market participants would use in pricing the asset or liability. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Fund. Unobservable inputs reflect the Fund’s own assumptions about the assumptions that market participants would use in pricing the asset or liability based on the best information available in the circumstances. Each investment is assigned a level based upon the observability of the inputs which are significant to the overall valuation. The three-tier hierarchy of inputs is summarized below.
| • | Level 1 - quoted prices in active markets for identical investments |
| • | Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.) |
| • | Level 3 - significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments) |
The fair value of debt instruments, such as bonds, and over-the-counter derivatives is generally based on market price quotations, recently executed market transactions (where observable) or industry recognized modeling techniques and are generally classified as Level 2. Pricing vendor inputs to Level 2 valuations may include quoted prices for similar investments in active markets, interest rate curves, coupon rates, currency rates, yield curves, option adjusted spreads, default rates, credit spreads and other unique security features in order to estimate the relevant cash flows which is then discounted to calculate fair values. If these inputs are unobservable and significant to the fair value, these investments will be classified as Level 3.
Where readily available market prices or relevant bid prices are not available for certain equity investments, such investments may be valued based on similar publicly traded investments, movements in relevant indices since last available prices or based upon underlying company fundamentals and comparable company data (such as multiples to earnings or other multiples to equity). Where an investment is valued using an observable input, by pricing vendors, such as another publicly traded security, the investment will be classified as Level 2. If management determines that an adjustment is appropriate based on restrictions on resale, illiquidity or uncertainty, and such adjustment is a significant component of the valuation, the investment will be classified as Level 3. An investment will also be classified as Level 3 where management uses company fundamentals and other significant inputs to determine the valuation.
Valuations reflected in this report are as of the report date. As a result, changes in valuation due to market events and/or issuer related events after the report date and prior to the issuance of the report are not reflected herein.
The following table summarizes the valuation of the Fund’s investments by the above fair value hierarchy levels as of June 30, 2026:
| Investments in Securities: |
Level 1 | Level 2 | Level 3 | Total | ||||||||||||
| Assets: |
| |||||||||||||||
| Underlying Portfolios | $ | — | $ | — | $ | 135,805 | $ | 135,805 | ||||||||
| Participation Notes | — | — | 4,584,591 | 4,584,591 | ||||||||||||
| Common Stocks | — | — | 22,443 | 22,443 | ||||||||||||
| Investments valued at NAV | — | — | — | 1,194,934,600 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total Investments in Securities | — | — | 4,742,839 | 1,199,677,439 | ||||||||||||
| Other Financial Instruments(a): | ||||||||||||||||
| Assets: | ||||||||||||||||
| Total Return Swaps | — | 66,326 | — | 66,326 | ||||||||||||
| Liabilities: | ||||||||||||||||
| Total Return Swaps | — | (927 | ) | — | (927 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Total | $ | — | $ | 65,399 | $ | 4,742,839 | $ | 1,199,742,838 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| (a) | Other financial instruments include derivative instruments, such as futures, forwards and swaps. Derivative instruments are valued at the unrealized appreciation (depreciation) on the instrument. Other financial instruments may also include swaps with upfront premiums, written options and written swaptions which are valued at market value. |
4